Nigel McCracken
Operationeel Directeur bij VIRAX BIOLABS GROUP LIMITED
Actieve functies van Nigel McCracken
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VIRAX BIOLABS GROUP LIMITED | Operationeel Directeur | 01-09-2023 | - |
Loopbaan van Nigel McCracken
Eerdere bekende functies van Nigel McCracken
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BERGENBIO ASA | Hoofd Techniek/Wetenschap/O&O | 01-01-2021 | 01-09-2023 |
Debiopharm International SA
 Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Directeur/Bestuurslid | 01-09-2014 | 01-04-2019 |
| Corporate Officer/Principal | 01-09-2014 | 01-04-2019 | |
| NUCANA PLC | Operationeel Directeur | - | - |
Opleiding van Nigel McCracken
| University of Strathclyde | Undergraduate Degree |
| King's College London | Graduate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 5 |
| Noorwegen | 2 |
| Zwitserland | 2 |
Operationeel
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BERGENBIO ASA | Health Technology |
| NUCANA PLC | Health Technology |
| VIRAX BIOLABS GROUP LIMITED | Finance |
| Bedrijven in privébezit | 1 |
|---|---|
Debiopharm International SA
Debiopharm International SA Pharmaceuticals: MajorHealth Technology Debiopharm International SA operates as a biopharmaceutical development company with focus on biologics and drug evaluation, licensing and development. It formulates and develops products for the treatment of cancer, endometriosis, uterine fibroids and hepatitis. The company was founded in 1979 and is headquartered in Lausanne, Switzerland. | Health Technology |
- Beurs
- Insiders
- Nigel McCracken
- Ervaring
